Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ESPERION-THERAPEUTICS-INC-13479951/news/U-S-FDA-Approves-Broad-New-Labels-for-Esperion-s-NEXLETOL-and-NEXLIZET-to-Prevent-Heart-Attac-46268032/?utm_source=whatsapp&utm_medium=social&utm_campaign=share